LSD1 regulated expression by removing methylation from H3K9 at the promoter of inflammatory response-related gene Tlr4. Tranylcypromine, an LSD1 inhibitor, inhibited the TLR4-NF-κB-JNK signaling axis and decreased renal inflammation in HBV-infected transgenic mice. The gene discussed is TLR4; the disease is inflammation.